
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENADRYL | McNeil Pharmaceutical | N-005845 DISCN | 1982-01-01 | 3 products |
| BENADRYL | McNeil Pharmaceutical | N-006146 DISCN | 1982-01-01 | 2 products, RLD |
| BENADRYL PRESERVATIVE FREE | McNeil Pharmaceutical | N-009486 DISCN | 1982-01-01 | 1 products, RLD |
| BENYLIN | Pfizer | N-006514 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| 24 / 7 life extra strength pain reliever pm | C200263 | 2025-12-16 |
| 24/7 life allergy relief | C200263 | 2025-12-16 |
| acetadryl | OTC monograph not final | 2013-11-12 |
| acetaflu nighttime | OTC monograph final | 2020-03-26 |
| acetaflu nighttime effervescent | OTC monograph final | 2020-03-26 |
| acetamax pm | OTC monograph not final | 2020-08-31 |
| acetaminophen 500mg diphenhydramine hcl 25mg | OTC monograph not final | 2020-11-16 |
| acetaminophen and diphenhydramine citrate | C200263 | 2025-10-02 |
| acetaminophen and diphenhydramine hcl | C200263 | 2025-12-19 |
| acetaminophen and diphenhydramine hydrochloride | C200263 | 2025-07-02 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 26 | 28 | 95 | 107 | 64 | 314 |
| Healthy volunteers/patients | — | — | — | 109 | 2 | 1 | 4 | 20 | 135 |
| Essential hypertension | D000075222 | — | I10 | 4 | 4 | 20 | 14 | 7 | 49 |
| Infections | D007239 | EFO_0000544 | — | 3 | 8 | 11 | 12 | 11 | 43 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 5 | 9 | 15 | 7 | 38 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 4 | 8 | 10 | 13 | 4 | 36 |
| Cough | D003371 | — | R05 | 4 | 5 | 6 | 6 | 8 | 29 |
| Covid-19 | D000086382 | — | U07.1 | 5 | 14 | 8 | 3 | 2 | 28 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 2 | 6 | 5 | 13 | 4 | 28 |
| Diabetic nephropathies | D003928 | EFO_0000401 | — | 2 | 3 | 5 | 12 | 7 | 27 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 13 | 14 | 2 | — | 3 | 31 |
| Lymphoma | D008223 | — | C85.9 | 10 | 15 | 2 | — | 1 | 26 |
| Multiple myeloma | D009101 | — | C90.0 | 8 | 13 | 4 | — | 1 | 24 |
| Leukemia | D007938 | — | C95 | 11 | 11 | 1 | — | 2 | 23 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 8 | 11 | 1 | — | 1 | 19 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 8 | 2 | — | 3 | 16 |
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 5 | 5 | — | 1 | 15 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 8 | 1 | 5 | — | — | 14 |
| Plasma cell neoplasms | D054219 | — | — | 4 | 6 | 2 | — | 1 | 13 |
| Lung neoplasms | D008175 | — | C34.90 | 4 | 7 | 2 | — | 1 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 8 | 7 | — | — | 1 | 15 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 4 | 5 | — | — | 1 | 10 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 6 | 4 | — | — | — | 9 |
| Hematologic neoplasms | D019337 | — | — | 2 | 6 | — | — | 1 | 9 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 6 | 3 | — | — | — | 9 |
| Hodgkin disease | D006689 | — | C81 | 6 | 4 | — | — | — | 9 |
| Neuralgia | D009437 | EFO_0009430 | — | — | 8 | — | — | 1 | 9 |
| B-cell lymphoma | D016393 | — | — | 6 | 3 | — | — | — | 9 |
| Fibrosis | D005355 | — | — | 3 | 7 | — | — | — | 8 |
| Hepatitis b | D006509 | — | — | 1 | 5 | — | — | 2 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug interactions | D004347 | — | — | 12 | — | — | — | 3 | 15 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 2 | — | — | — | 3 | 5 |
| Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | 1 | 4 |
| Apnea | D001049 | — | R06.81 | 1 | — | — | — | 2 | 3 |
| Pure autonomic failure | D054970 | — | — | 3 | — | — | — | — | 3 |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | — | — | — | 1 | 2 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | 1 | — | — | — | 1 | 2 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 2 | — | — | — | — | 2 |
| Food-drug interactions | D018565 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Parasomnias | D020447 | — | G47.5 | — | — | — | — | 4 | 4 |
| Dyssomnias | D020920 | — | — | — | — | — | — | 3 | 3 |
| Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | — | — | 2 | 2 |
| Arteriovenous fistula | D001164 | — | Q27.3 | — | — | — | — | 2 | 2 |
| Suicidal ideation | D059020 | EFO_0004320 | R45.851 | — | — | — | — | 2 | 2 |
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 2 | 2 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 2 | 2 |
| Whooping cough | D014917 | EFO_0000650 | A37 | — | — | — | — | 2 | 2 |
| Diarrhea | D003967 | — | R19.7 | — | — | — | — | 2 | 2 |
| Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | — | — | 1 | 1 |
| Drug common name | Diphenhydramine |
| INN | diphenhydramine |
| Description | Diphenhydramine is an ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. It has a role as a H1-receptor antagonist, an antiemetic, a sedative, an anti-allergic agent, a muscarinic antagonist, an antiparkinson drug, an antipruritic drug, a local anaesthetic, an antidyskinesia agent, an antitussive and a oneirogen. It is an ether and a tertiary amino compound. |
| Classification | Small molecule |
| Drug class | first-generation antihistamine (ethanolamine), anticholinergic, hallucinogen (deliriant) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CN(C)CCOC(c1ccccc1)c1ccccc1 |
| PDB | — |
| CAS-ID | 58-73-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL657 |
| ChEBI ID | 4636 |
| PubChem CID | 3100 |
| DrugBank | DB01075 |
| UNII ID | 8GTS82S83M (ChemIDplus, GSRS) |



















































